Autoimmune diseases Drugs: Medicare Part D Spending

• 72medicines with Part D spending (calendar year 2024)

Each number has its full source under its own list below.

1. 1Stelara*Ustekinumab · $26,534.27 per unit$3.4 billion
2. 2Orencia ClickjectAbatacept · $1,408.17 per unit$570.2 million
3. 3CopaxoneGlatiramer Acetate · $428.54 per unit$257.2 million
4. 4Actemra ActpenTocilizumab · $1,291.60 per unit$236.1 million
5. 5Mesalamine*Mesalamine · $3.24 per unit$204.4 million
6. 6OrenciaAbatacept · $1,406.77 per unit$183.9 million
7. 7CelecoxibCelecoxib · $0.44 per unit$164.7 million
8. 8TecfideraDimethyl Fumarate · $149.87 per unit$162.8 million
9. 9Actemra*Tocilizumab · $986.45 per unit$131.9 million
10. 10Clobetasol PropionateClobetasol Propionate · $0.86 per unit$126.9 million
11. 11Baclofen*Baclofen · $0.19 per unit$88.4 million
12. 12Glatiramer AcetateGlatiramer Acetate · $167.78 per unit$79.2 million
13. 13GlatopaGlatiramer Acetate · $163.08 per unit$75.2 million
14. 14Dimethyl FumarateDimethyl Fumarate · $15.97 per unit$67.2 million
15. 15OrenciaAbatacept/Maltose · $1,431.35 per unit$64.6 million

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

• Bones and joints
• Gut health
• Brain and nerves
• Skin and hair
• Kidney health